CF — CF Industries Holdings, Inc.

Market sentiment is cautious after Q2 2026 missed consensus on both revenue and EPS due to the Yazoo City outage and lower volumes. Sell-side targets cluster around $124-$128, implying limited near-term upside, and forward EPS estimates have been revised downward from $18+ toward $15 over the past 90 days. The 20% dividend raise and Blue Point One groundbreaking provide positive offset but have not removed near-term skepticism.

Revenue has accelerated over the last two reported quarters: Q2 2026 revenue was $2.222B versus $1.890B in Q2 2025 (+17.6%), and Q1 2026 revenue was $1.986B versus $1.663B (+19.4%). Margins have expanded sharply—TTM operating margin is 38.1% and Q2 2026 gross margin was 51.5%—but reported Q2 earnings were flattered by a roughly $170M pre-tax litigation settlement and hurt by the Yazoo City outage. Excluding the settlement, Q2 EPS would be closer to $3.86 and TTM EPS closer to $12.80, still strong. This is a genuine up-cycle in nitrogen earnings, not just a one-quarter blip, but the durability of 38% operating margins is the key uncertainty.

At $125.70, the stock trades at 9.3x TTM EPS and roughly 8.3x consensus forward EPS of $15.19, below CF's 5-year average P/E of 10.6x. Price-to-sales of 2.50x is above the 5-year average of 2.11x, reflecting the much higher current margin profile; if margins normalize, that sales multiple will look less comfortable. Dividend yield is 1.78% with a recent 20% dividend raise. Overall, valuation is neutral-to-slightly-cheap on earnings but not demonstrably cheap on sales, consistent with the score's 'Neutral vs. its own history' label.

The market is applying roughly 8-9x forward earnings to CF, which is effectively pricing in margin normalization rather than durable $15 EPS. If nitrogen supply stays tight through 2027 and Blue Point creates real low-carbon ammonia value, the multiple can re-rate toward the historical 10x area. If operating margins fall back toward the mid-20s, EPS could drop toward $8-$10, making even 8x look expensive. The stock is not pricing in aggressive growth; it is asking investors to trust that the current high-margin cycle has more room to run.

As of 2026-08-27, RSI stood at 56.8, which is neutral rather than overbought or oversold. Price was 3.7% above the 20-day SMA, 6.9% above the 50-day SMA, and 18.0% above the 200-day SMA, so the trend is upward but extended relative to the 200-day. A pullback toward the 50-day moving average in the $118-$120 zone would be a more attractive entry than chasing strength at current levels.

• North American natural gas advantage versus higher European/Asian energy costs supports CF's production margin
• 45Q carbon-sequestration credits and clean-hydrogen policy underpin Blue Point One economics
• Interest rates set the hurdle rate for CF's $3.7B low-carbon ammonia investment and competing capital projects
• Corn, soybean, and other grain prices drive farmer planting decisions and nitrogen application demand
• Global nitrogen supply additions or export restrictions can quickly reset nitrogen price expectations

• Q3 2026 earnings in late October/early November 2026: evidence that the Yazoo City outage is resolved and volumes are recovering
• Blue Point One construction, financing, and CCS pipeline milestones with Enbridge/1PointFive and Linde
• Continued shareholder returns: the 20% dividend increase and buyback program could expand if FCF stays strong
• Nitrogen price strength into fall ammonia application season and potential winter European gas price spikes
• Stabilization of analyst estimates after the cuts from $18 toward $15 could be a positive inflection point

• Nitrogen margin normalization: high prices attract new supply, and lower global gas costs would shrink CF's cost advantage
• Blue Point One execution and cost-overrun risk: $3.7B project, CF owns 40%, and CCS infrastructure is complex
• Operational outages like the Yazoo City event in Q2 2026 could recur and pressure volumes
• Agricultural downturn or weak farmer economics could reduce nitrogen application and fertilizer pricing power
• Reported TTM EPS is flattered by the Q2 2026 litigation settlement; the one-off gain is not repeatable

CF is a high-quality, low-cost nitrogen producer with a strong balance sheet, TTM free cash flow around $1.9B, and a reasonable valuation at roughly 8-9x forward earnings. The main question is whether current nitrogen margins are sustainable; if they are, the stock is undervalued, and Blue Point adds long-term optionality. I lean Bullish on a 12-24 month horizon, while recognizing this is a cyclical commodity business and position sizing should account for that.

I applied an 8.7x multiple to consensus forward EPS of $15.187, a modest discount to CF's 5-year average P/E of 10.62x and slightly below the current TTM P/E of 9.3x, to reflect commodity-cycle risk and expected margin normalization. That calculation yields $132.13, which is above the recent analyst average target of $124.40 but below the full consensus target of $128.40 plus a reasonable quality/balance-sheet premium.